Effects of insulin detemir on balloon catheter injured carotid artery in Zucker fatty rats

Journal of Diabetes and its Complications

Volumn 26, Issue 6, 2012, Pages 470-475

  Murthy, Subramanyam N ^a   Pankey, Edward A ^a   Banka, Ajaz A ^a   Badejo Jr , Adeleke M ^a   Wekerle, Ryan ^a   Vilija, Vaitaitis ^a   Izadpanah, Reza ^b   Kadowitz, Philip J ^a   Fonseca, Vivian A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carotid injury; Detemir; Insulin resistance; Intimal hyperplasia; NPH

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN DETEMIR; ISOPHANE INSULIN; MANGANESE SUPEROXIDE DISMUTASE; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; BLOOD VESSEL INJURY; CAROTID ARTERY INJURY; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; INFLAMMATION; INSULIN RESISTANCE; INSULIN TREATMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; ZUCKER DIABETIC FATTY RAT;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; FEMALE; HYPERPLASIA; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INSULIN, ISOPHANE; INSULIN, LONG-ACTING; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, ZUCKER; TUNICA INTIMA;

EID: 84868636342     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.05.019     Document Type: Article

References (26)

1. T. Almadal, H. Scharling, J.S. Jensen, and H. Vestrgaard Independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death Archives of Internal Medicine 12 2004 1422 1426
2. A. Chatagnon, S. Bougel, L. Perriaud, J. Lachuer, J. Benhattar, and R. Dante Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells Carcinogenesis 30 2009 28 34
3. A. Chaudhuri, D. Janicke, M.F. Wilson, D. Tripathy, R. Garg, and A. Bandyopadhyay Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction Circulation 109 2004 849 854
4. P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, W. Hamouda, E. Assian, and S. Ahmad Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? The Journal of Clinical Endocrinology and Metabolism 86 7 2001 Jul 3257 3265
5. G. de Simone, R.B. Devereux, M. Chinali, E.T. Lee, J.M. Galloway, A. Barac, J.A. Panza, and B.V. Howard Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study Journal of Hypertension 2009 Oct 19. [Epub ahead of print]
6. C.V. Desouza, S.N. Murthy, J. Diez, B. Dunne, A.S. Matta, V.A. Fonseca, and D.B. McNamara Differential effects of peroxisome proliferator activator receptor α and γ ligands on intimal hyperplasia after balloon catheter induced vascular injury in Zucker rats Journal of Cardiovascular Pharmacology Therapeutic 8 2003 297 306
7. C. Desouza, H. Salazar, B. Cheong, J. Murgo, and V. Fonseca Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring Diabetes Care 26 2003 1485 1489
8. C.V. Desouza, G.B. Bolli, and V. Fonseca Hypoglycemia, diabetes, and cardiovascular events Diabetes Care 33 6 2010 Jun 1389 1394
9. H.C. Gerstein, and The ORIGIN Trial Investigators Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention) American Heart Journal 155 2008 26e6 32e6
10. S. Halimi Acute consequences of hypoglycaemia in diabetic patients Diabetes & Metabolism 36 Suppl. 3 2010 S75 S83
11. D.B. McNamara, S.N. Murthy, A.N. Fonseca, C.V. Desouza, P.J. Kadowitz, and V.A. Fonseca Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention Canadian Journal of Physiology and Pharmacology 87 1 2009 37 50
12. S.N. Murthy, D.F. Obregon, N.N. Chattergoon, N.A. Fonseca, D. Mondal, B.J. Dunne, J. Diez, J.R. Jeter Jr., P.J. Kadowitz, K.C. Agrawal, D.B. McNamara, and V.A. Fonseca Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation and intimal hyperplasia in Sprague Dawley rats fed a high methionine diet Metabolism 54 5 2005 645 652
13. S.N. Murthy, S. Sukhanov, J. McGee, J.A. Greco, S. Chandra, P. Delafontaine, P.J. Kadowitz, D.B. McNamara, and V.A. Fonseca Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by IGF-1 mediated reduction in oxidative stress Molecular and Cellular Biochemistry 330 1-2 2009 1 8 [Epub 2009 Apr 10]
14. S.N. Murthy, R.C. St Hilaire, D.B. Casey, A.M. Badejo Jr., J. McGee, D.B. McNamara, P.J. Kadowitz, and V.A. Fonseca The synthetic analog of GLP-1, exenatide reduces intimal hyperplasia in insulin resistant rats Diabetes and Vascular Disease Research 7 2 2010 138 144 [Epub 2010 Mar 2]
15. S.N. Murthy, C.V. Desouza, N.W. Bost, R.C. St Hilaire, D.B. Casey, A.M. Badejo, J.S. Dhaliwal, J. McGee, D.B. McNamara, P.J. Kadowitz, and V.A. Fonseca Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats Diabetes 59 12 2010 3240 3246 [Epub 2010 Sep 28]
16. A.C. Newby, and A.B. Zaltsman Molecular mechanisms of intimal hyperplasia The Journal of Pathology 190 2000 300 309
17. S. Park, S.P. Marso, Z. Zhou, F. Foroudi, E.J. Topol, and A.M. Lincoff Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus Circulation 104 2001 815 819
18. S.R. Preis, M.J. Pencina, S.J. Hwang, R.B. D'Agostino Sr., P.J. Savage, D. Levy, and C.S. Fox Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study Circulation 120 3 2009 212 220 [Epub Jul 6, 2009]
19. A. Rolla Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety The American Journal of Medicine 121 6 Suppl 2008 S9 S19
20. M. Slawik, M. Schories, B.A. Busse Grawitz, M. Reincke, and K.G. Peterson Treatment with insulin glargine does not suppress serum IGF-1 Diabetic Medicine 23 2006 814 817
21. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Analytical Biochemistry 150 1985 76 85
22. M.M. van Greevenbroek, V.M. Vermeulen, and T.W. de Bruin Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19 Journal of Lipid Research 45 2004 1148 1154
23. J. Westerbacka, R. Bergholm, M. Tiikkainen, and H. Yki-Jarvinen Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects Arteriosclerosis, Thrombosis, and Vascular Biology 24 2004 320 324 [Epub 2003 Dec]
24. R.J. Wright, and B.M. Frier Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes/Metabolism Research and Reviews 24 5 2008 353 363
25. G. Zeng, F.H. Nystrom, L.V. Ravichandran, L.N. Cong, M. Kirby, and H. Mostowski Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells Circulation 101 2000 1539 1545
26. S. Zoungas, A. Patel, J. Chalmers, B.E. de Galan, Q. Li, L. Billot, M. Woodward, T. Ninomiva, B. Neal, S. MacMahon, D.E. Grobbe, A.P. Kenge, M. Marre, S. Heller ADVANCE Collaborative Group Severe hypoglycemia and risks of vascular events and death The New England Journal of Medicine 363 15 2010 1410 1418